Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05659524 · ClinicalTrials.gov registry record · NA
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
A NA study of Pituitary Tumor, sponsored by Lori Wood.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 2
- Study locations
NCT05659524 is a NA study of Pituitary Tumor that is actively recruiting participants, run by Lori Wood. The registered enrollment target is 140 participants, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05659524, a NA study of Pituitary Tumor, is actively recruiting participants, sponsored by Lori Wood.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.
Conditions Studied
Interventions
- OTHER Nasal saline irrigation
Study Locations (2)
Arizona
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05659524
The ClinicalTrials.gov registry entry for NCT05659524 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower). The listed sponsor is Lori Wood, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pituitary Tumor appearing as the primary indexed condition, and to 1 intervention - of which Nasal saline irrigation is the first listed.
NCT05659524 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Ohio.
Frequently Asked Questions
What is clinical trial NCT05659524 about?
NCT05659524 is a clinical study titled "Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery". This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes f...
What is the current status of trial NCT05659524?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2020-12-18. Estimated completion is 2029-12-31.
What conditions does trial NCT05659524 study?
This clinical trial studies the following conditions: Pituitary Tumor.
What interventions are being tested in trial NCT05659524?
The interventions under investigation include: Nasal saline irrigation (OTHER).
Who is sponsoring clinical trial NCT05659524?
This trial is sponsored by Lori Wood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05659524 being conducted?
This trial has 2 study locations across Arizona, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pituitary Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Pituitary Tumor Surveillance: Pathogenic Correlation
RECRUITING
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.